Molecular structure of Doxepin hydrochloride, CAS Number: 1229-29-4
Doxepin hydrochloride (CAS 1229-29-4)
Application:
Doxepin hydrochloride is a highly potent histamine H1 antagonist with affinity to H4 receptor
CAS Number:
1229-29-4
Purity:
≥98%
Molecular Weight:
315.84
Molecular Formula:
C19H21NO•HCl
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Doxepin hydrochloride is a highly potent Histamine H1 Receptor (histamine H1) antagonist. Doxepin hydrochloride also binds to histamine H4 receptor. Doxepin hydrochloride is an inhibitor of AR and mAChR M.
Doxepin hydrochloride (CAS 1229-29-4) References
- Discovery of a novel member of the histamine receptor family. | Nguyen, T., et al. 2001. Mol Pharmacol. 59: 427-33. PMID: 11179435
- Sleep-Promoting Effects and Possible Mechanisms of Action Associated with a Standardized Rice Bran Supplement. | Yang, H., et al. 2017. Nutrients. 9: PMID: 28524102
- Trichoteiromania: Good Response to Treatment with N-Acetylcysteine. | Salas-Callo, CI. and Pirmez, R. 2019. Skin Appendage Disord. 5: 242-245. PMID: 31367603
- Anti-inflammatory effects of doxepin hydrochloride against LPS-induced C6-glioma cell inflammatory reaction by PI3K-mediated Akt signaling. | Tao, F., et al. 2020. J Biochem Mol Toxicol. 34: e22424. PMID: 31743544
- The use of dupilumab for the treatment of recalcitrant brachioradial pruritus. | Abel, MK., et al. 2021. JAAD Case Rep. 10: 69-71. PMID: 33816733
- A Meta-Analysis of the Effect of Abdominal Acupuncture on Post-Stroke Depression. | Su, IJ., et al. 2021. Med Acupunct. 33: 269-277. PMID: 34471445
- Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults. | Radomski, TR., et al. 2022. JAMA Netw Open. 5: e2148599. PMID: 35166780
- Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. | Jin, Z., et al. 2022. Pharmaceutics. 14: PMID: 36297505
- Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. | García-Arieta, A., et al. 2023. Pharmaceutics. 15: PMID: 36839924
- Determination of doxepin hydrochloride in spiked human plasma and capsule after derivatization with eosin Y using resonance Rayleigh scattering, second-order scattering and frequency doubling scattering methods. | Geogin, J., et al. 2023. Luminescence. 38: 753-761. PMID: 37060157
- Case report: Spinal cord stimulation in the treatment of pediatric erythromelalgia. | Zuo, L., et al. 2023. Front Neurol. 14: 1143241. PMID: 37273700
- Review of clinical and animal studies comparing the cardiovascular effects of doxepin and other tricyclic antidepressants. | Luchins, DJ. 1983. Am J Psychiatry. 140: 1006-9. PMID: 6346907
- [3H]doxepin interactions with histamine H1-receptors and other sites in guinea pig and rat brain homogenates. | Tran, VT., et al. 1981. Eur J Pharmacol. 70: 501-9. PMID: 7238574
Inhibitor of:
AR, Histamine H1 Receptor, mAChR M, and SMPDL3B.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Doxepin hydrochloride, 1 g | sc-203930 | 1 g | $51.00 |